Skip to content

Clinical study of tendon acupuncture combined with in the treatment of hemiplegic shoulder pain

Clinical study of tendon acupuncture combined with in the treatment of hemiplegic shoulder pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000568
Enrollment
Unknown
Registered
2024-10-17
Start date
2023-09-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegic shoulder pain

Interventions

Treatment group:Tendon needle combined rtms and Conventional treatment(Local hot compress, transcutaneous nerve electrical stimulation and stretching training, control blood pressure, blood sugar, blo
Control group:rTMS combined with Conventional treatment(Local hot compress, transcutaneous nerve electrical stimulation and stretching training, control blood pressure, blood sugar, blood lipids, nutr

Sponsors

Xuzhou Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Only those listed below can be included. 1) Meet the diagnostic standards of traditional Chinese and Western medicine; 2) The person or legal guardian agrees and has signed the informed consent form; 3) Patients complaining of hemiplegic shoulder pain with VAS =4 points; 4) Patients aged 30-70 years old with a course of 15 days to 6 months clear consciousness stable vital signs and can cooperate with examination and treatment;

Exclusion criteria

Exclusion criteria: Any of the following shall be excluded. 1) does not meet the above inclusion criteria; 2) Shoulder pain caused by shoulder fixation contracture and previous injuries or surgeries thalamic lesions; 3) Combined with serious heart liver kidney endocrine system and hematopoietic system diseases; 4) Those who are unable to cooperate with cognitive impairment mental illness etc. and have a history of severe heart liver and kidney diseases epilepsy and atrial fibrillation; 5) Patients with abnormal coagulation function and skin infection; 6) is participating in other trials that affect the evaluation of the results of this study; 7) Those who do not cooperate withdraw on their own and cannot continue treatment due to adverse events. 8) Those who are unable to tolerate or accept acupuncture and manual manipulation (including pregnant women);

Design outcomes

Primary

MeasureTime frame
(Visual Analogue Scale,VAS);Fugl-Meyer scale;

Secondary

MeasureTime frame
Musculoskeletal ultrasound;

Countries

china

Contacts

Public Contactwangmi

Xuzhou Rehabilitation Hospital

9031912@qq.com15325218658

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026